By Ronnie Harui Fujifilm plans to invest $200 million in two subsidiaries in the U.S. to expand its global cell therapy contract development and manufacturing capabilities, the Japanese.
High-flying Fujifilm splashes $200M to beef up cell therapy capacity fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC).